Peggy Farnham, PhD

Dr. Farnham is the William M. Keck Professor of Biochemistry, Professor of Cancer Biology, and the former Chair of the Department of Biochemistry and Molecular Biology at the Keck School of Medicine at the University of Southern California in Los Angeles, California. Dr. Farnham received her bachelor’s degree from Rice University, her Ph.D. from Yale University, and performed her post-doctoral training at Stanford University. Dr. Farnham previously held Professorships at the McArdle Laboratory for Cancer Research at the University of Wisconsin-Madison and at the University of California-Davis where she was the Associate Director of the UC Davis Genome Center. Dr. Farnham is an international leader in the study of chromatin regulation and its control of transcription factor binding and function. She is a member of an international consortia of genomic scientists working on the ENCODE (Encyclopedia of DNA elements) Project and a member of an NIH Roadmap Reference Epigenome Mapping Center. Based on her contributions to biomedical research, she was elected as a fellow of AAAS in 2010 and in 2012 she received the ASBMB Herbert A Sober Award, which recognizes outstanding biochemical and molecular biological research with particular emphasis on the development of methods and techniques to aid in research.

Research Interests: transcriptional genomics, genomic technologies
Diseases Models: cancer cells and tissues, cultured neuroepithelial cells
Consortia: ENCODE, Roadmap Epigenome Mapping Centers, PsychENCODE

• AAAS Fellow, 2010
• ASBMB Herbert A. Sober Award, 2012

• Rice University, Houston, Texas — BA — 1978 — Biochemistry
• Yale University, New Haven, CT — PhD — 1982 — Molecular Biochemistry
• Stanford University, Palo Alto, CA — Postdoc — 1986 — Molecular Biology

• Characterization of a novel family of human transcription factors that bind at +240 downstream of the transcription start site.
  NIH · R01GM133450 · Apr 1, 2020 – Mar 31, 2024 · Role: Principal Investigator
• Development of a novel promoter tagging technology to identify enhancer targets
  NIH · R21HG009742 · Sep 1, 2017 – Jun 30, 2019 · Role: Principal Investigator
• The USC PsychENCODE Project
  NIH · U01MH103346 · Jun 15, 2014 – May 31, 2018 · Role: Co-Principal Investigator
• Development of a nuclease-mediated technology to validate chromatin hubs
  NIH · R21HG006761 · Apr 24, 2012 – Mar 31, 2015 · Role: Principal Investigator
• Mechanisms of Transcriptional Regulation in Stem Cells
  NIH · R56DK067889 · Sep 21, 2009 – Jul 31, 2010 · Role: Principal Investigator
• Prostate Cancer Risk Enhancers
  NIH · R01CA136924 · Dec 1, 2008 – Jan 31, 2021 · Role: Principal Investigator
• Scaling the ChIP-chip assay to improve analysis of clinical biospecimens
  NIH · R21CA128471 · Jul 1, 2007 – Jun 30, 2010 · Role: Principal Investigator
• Mechanisms of Transcriptional Regulation in Stem Cells
  NIH · R01DK067889 · Jul 1, 2005 – May 31, 2010 · Role: Principal Investigator
• THE ROLE OF FAF KINASE IN CELL PROLIFERATION
  NIH · R01CA059524 · Mar 15, 1994 – Jan 31, 1997 · Role: Principal Investigator
• Transcriptional Regulation of Growth Related Genes
  NIH · R01CA045240 · Apr 1, 1987 – May 31, 2013 · Role: Principal Investigator
• TRANSCRIPTIONAL REGULATION OF GROWTH-RELATED GENES
  NIH · R29CA045240 · Apr 1, 1987 – Mar 31, 1992 · Role: Principal Investigator
• CELL CYCLE REGULATION OF THE DIHYDROFOLATE REDUCTASE GEN
  NIH · F32GM008853 · Jun 30, 1985 · Role: Principal Investigator
• University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG)
  NIH · P30CA014089 · Apr 1, 1980 – Nov 30, 2026 · Role: Principal Investigator

• ASBMB Award
• Mapping human epigenomes
• E2F1
• ENCODE

• An, Woojin
• Rhie, Suhn
• Liang, Gangning
• Lieber, Michael
• Lenz, Heinz-Josef
• Haiman, Christopher